Search Ontology:
ChEBI
alpha-L-Fucp-(1->2)-[beta-D-Galp-(1->3)-alpha-D-GalpNAc-(1->3)]-beta-D-Galp-(1->4)-D-GlcpNAc
- Term ID
- CHEBI:68674
- Synonyms
-
- 6-deoxy-alpha-L-galactopyranosyl-(1->2)-[beta-D-galactopyranosyl-(1->3)-2-acetamido-2-deoxy-alpha-D-galactopyranosyl-(1->3)]-beta-D-galactopyranosyl-(1->4)-2-acetamido-2-deoxy-D-glucopyranose
- alpha-L-Fuc-(1->2)-[beta-D-Gal-(1->3)-alpha-D-GalNAc-(1->3)]-beta-D-Gal-(1->4)-D-GlcNAc
- alpha-L-fucopyranosyl-(1->2)-[beta-D-galactopyranosyl-(1->3)-2-acetamido-2-deoxy-alpha-D-galactopyranosyl-(1->3)]-beta-D-galactopyranosyl-(1->4)-2-acetamido-2-deoxy-D-glucopyranose
- alpha-L-fucosyl-(1->2)-[beta-D-galactosyl-(1->3)-N-acetyl-alpha-D-galactosaminyl-(1->3)]-beta-D-galactosyl-(1->4)-N-acetyl-D-glucosamine
- Fucalpha1-2(Galbeta1-3GalNAcalpha1-3)Galbeta1-4GlcNAc
- Galb1-3GalNAca1-3(Fuca1-2)Galb1-4GlcNAc
- Galbeta1-3GalNAcalpha1-3(Fucalpha1-2)Galbeta1-4GlcNAc
- O-6-deoxy-alpha-L-galactopyranosyl-(1->2)-O-[O-beta-D-galactopyranosyl-(1->3)-2-(acetylamino)-2-deoxy-alpha-D-galactopyranosyl-(1->3)]-O-beta-D-galactopyranosyl-(1->4)-2-(acetylamino)-2-deoxy-D-glucopyranose
- Definition
- An amino pentasaccharide comprised of a tetrasaccharide chain of β-D-galactosyl, N-acetyl-α-D-galactosaminyl, β-D-galactosyl and N-acetyl-D-glucosaminyl residues linked sequentially (1→3), (1→3) and (1→4), with an α-L-fucosyl residue linked (1→2) to the galactosyl residue proximal to the reducing-end glucosaminyl residue.
- References
-
- glygen:G71451AZ
- glytoucan:G71451AZ
- pubmed:19443021
- pubmed:25568069
- pubmed:31537530
- Ontology
- ChEBI ( EBI )
Phenotype
Phenotype resulting from alpha-L-Fucp-(1->2)-[beta-D-Galp-(1->3)-alpha-D-GalpNAc-(1->3)]-beta-D-Galp-(1->4)-D-GlcpNAc
Phenotype where environments contain alpha-L-Fucp-(1->2)-[beta-D-Galp-(1->3)-alpha-D-GalpNAc-(1->3)]-beta-D-Galp-(1->4)-D-GlcpNAc
Phenotype modified by environments containing alpha-L-Fucp-(1->2)-[beta-D-Galp-(1->3)-alpha-D-GalpNAc-(1->3)]-beta-D-Galp-(1->4)-D-GlcpNAc
Phenotype affecting alpha-L-Fucp-(1->2)-[beta-D-Galp-(1->3)-alpha-D-GalpNAc-(1->3)]-beta-D-Galp-(1->4)-D-GlcpNAc
Human Disease Model